Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Litchman

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Dermatologic Clinics|June 28, 2025
Lesional Markers and Precursors of MelanomaValerie Foy, Graham H Litchman
Journal of Drugs in Dermatology : JDD|February 4, 2021
The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based InteractionsJustin W Marson, Graham H Litchman, Darrell S Rigel
The Journal of Clinical and Aesthetic Dermatology|June 4, 2026
Severe Nail Psoriasis and Early Psoriatic Arthritis: Illustrative Cases Confirming That Severity of Disease Is Not Solely Dependent on the Extent of Body Surface AreaGraham H Litchman, Diego Ruiz Dasilva, James Q Del Rosso
Journal of Drugs in Dermatology : JDD|October 5, 2019
Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by DermatologistsTeplitz Rebeca, Prado Giselle, Graham H. Litchman, et al.
The Journal of Clinical and Aesthetic Dermatology|July 16, 2026
Resolution of Long-Standing Irritable Bowel Syndrome Symptoms After Treatment of Psoriasis With RisankizumabJose Gaspar de Alba, Marley Cutrona, Ahuva Cices, et al.
Clinical Nuclear Medicine|July 1, 1986
Computerized blood-flow analysis in osteochondritis dissecansR W McCullough, E J Gandsman, H Litchman, et al.
Current Medical Research and Opinion|May 7, 2020
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinomaGraham H Litchman, Alison L Fitzgerald, Sarah J Kurley, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19Justin W Marson, Rebecca M Chen, Maham Ahmad, et al.
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Dermatology and Therapy|March 30, 2022
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working GroupAaron S Farberg, Justin W Marson, Alex Glazer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Dermatologic Clinics|June 28, 2025
Lesional Markers and Precursors of MelanomaValerie Foy, Graham H Litchman
Journal of Drugs in Dermatology : JDD|February 4, 2021
The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based InteractionsJustin W Marson, Graham H Litchman, Darrell S Rigel
The Journal of Clinical and Aesthetic Dermatology|June 4, 2026
Severe Nail Psoriasis and Early Psoriatic Arthritis: Illustrative Cases Confirming That Severity of Disease Is Not Solely Dependent on the Extent of Body Surface AreaGraham H Litchman, Diego Ruiz Dasilva, James Q Del Rosso
Journal of Drugs in Dermatology : JDD|October 5, 2019
Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by DermatologistsTeplitz Rebeca, Prado Giselle, Graham H. Litchman, et al.
The Journal of Clinical and Aesthetic Dermatology|July 16, 2026
Resolution of Long-Standing Irritable Bowel Syndrome Symptoms After Treatment of Psoriasis With RisankizumabJose Gaspar de Alba, Marley Cutrona, Ahuva Cices, et al.
Clinical Nuclear Medicine|July 1, 1986
Computerized blood-flow analysis in osteochondritis dissecansR W McCullough, E J Gandsman, H Litchman, et al.
Current Medical Research and Opinion|May 7, 2020
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinomaGraham H Litchman, Alison L Fitzgerald, Sarah J Kurley, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19Justin W Marson, Rebecca M Chen, Maham Ahmad, et al.
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Dermatology and Therapy|March 30, 2022
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working GroupAaron S Farberg, Justin W Marson, Alex Glazer, et al.
Pageof 2